Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Renvorab IT 20mg/150mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Leeford Healthcare Ltd

Salt Composition

Rabeprazole (20mg) + Itopride (150mg)

Overview Renvorab IT 20mg/150mg Capsule SR

Gastro-esophageal reflux disease (GERD) and peptic ulcer disease are effectively managed with the dual-action formulation, Renvorab IT 20mg/150mg sustained-release capsules. This medication alleviates common acidity symptoms, such as burning sensations in the chest, stomach aches, and irritation, by neutralizing stomach acid and facilitating gas expulsion for enhanced comfort. Dosage and treatment duration for Renvorab IT 20mg/150mg SR capsules are determined by your physician, considering your individual needs and response. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications you're using is essential, as interactions are possible. Common, typically transient, side effects include abdominal pain, altered bowel habits (diarrhea or constipation), headaches, gas, fatigue, and increased salivation. Report any concerning side effects promptly to your doctor. Due to potential drowsiness and dizziness, avoid driving or activities demanding alertness until the medication's effects are known. Alcohol consumption should be avoided as it may intensify sleepiness. Dietary adjustments, including consuming cold milk and avoiding stimulants like hot beverages, spicy foods, and chocolate, can complement treatment. Prior to commencing therapy, inform your physician of any pre-existing liver conditions, pregnancy, pregnancy plans, or breastfeeding.

Primary Ingredients of Renvorab IT 20mg/150mg Capsule SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Renvorab IT 20mg/150mg Capsule SR

Heartburn and ulcers (GERD, PUD)

Major Benefits of Renvorab IT 20mg/150mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or fracturing it. Renvorab IT 20mg/150mg Extended-Release Capsules should be taken on an empty stomach.

Common Side effects of Renvorab IT 20mg/150mg Capsule SR:

  • Stomach pain
  • Diarrhea
  • Constipation
  • Headache
  • Dizziness
  • Flatulence
  • Weakness
  • Flu-like symptoms
  • Increased saliva production
  • Insomnia (difficulty in sleeping)
  • Back pain

How to use Renvorab IT 20mg/150mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Renvorab IT 20mg/150mg SR Capsules. Ingest the capsule whole; do not damage it in any way. Administer this medication on an empty stomach.

How Renvorab IT 20mg/150mg Capsule SR works:

Renvorab IT 20mg/150mg sustained-release capsules contain rabeprazole and itopride, working synergistically to alleviate acid-related digestive issues. Rabeprazole, a proton pump inhibitor (PPI), diminishes stomach acid production, providing relief from indigestion and heartburn. Itopride, a prokinetic agent, acts centrally on the brain's vomiting center and peripherally on the upper gastrointestinal tract, enhancing gastric and intestinal motility to facilitate food passage.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Renvorab IT 20mg/150mg SR capsules with alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Renvorab IT 20mg/150mg sustained-release capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Renvorab IT 20mg/150mg sustained-release capsules while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Renvorab IT 20mg/150mg sustained-release capsules might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving is inadvisable if these effects are experienced.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Renvorab IT 20mg/150mg sustained-release capsules in patients with renal impairment is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with severe hepatic impairment should exercise caution when using Renvorab IT 20mg/150mg sustained-release capsules. Dosage modification of Renvorab IT 20mg/150mg sustained-release capsules may be necessary. Physician consultation is advised.

What if you forget to take Renvorab IT 20mg/150mg Capsule SR :

Should you forget a Renvorab IT 20mg/150mg SR Capsule dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Renvorab IT 20mg/150mg Capsule SR

LabelValue
Developing Good Habits No.
Treatment Category Gastrointestinal system
Renvorab IT 20mg/150mg Ca...
156
MRP 180
13% off